7/25/2024  12:56:23 PM Chg. -0.3500 Volume Bid1:47:50 PM Ask2:01:22 PM Market Capitalization Dividend Y. P/E Ratio
44.8500EUR -0.77% 1,415
Turnover: 63,061
44.6000Bid Size: 150 44.7000Ask Size: 150 2.47 bill.EUR - -

Business description

BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
 

Management board & Supervisory board

CEO
Dr. Daniel Koller
Management board
Dr. Thomas von Planta, Laura Hamill, Dr. Pearl Huang, Prof. Dr. Mads Krogsgaard Thomsen, Camilla Soenderby
Supervisory board
Dr. Clive Meanwell
 

Company data

Name: BB Biotech AG
Address: Schwertstraße 6,CH-8200 Schaffhausen/Schweiz
Phone: +41-52-624-0845
Fax: -
E-mail: info@bbbiotech.com
Internet: www.bbbiotech.com
Industry: Financial
Sector: Specialty Finance
Sub sector: Diversified Financial
End of financial year: 12/31
Free Float: 97.00%
IPO date: 12/10/1997

Investor relations

Name: Dr. Silvia Siegfried-Schanz
IR phone: +41-44-267-7266
IR Fax: -
IR e-mail: ssc@bellevue.ch

Company calendar

CW 30 | 7/26/2024 Interim Report 2nd Quarter/6 Months
CW 43 | 10/25/2024 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
96.47%
Lazard Asset Management LLC, New York, USA
 
3.53%